Verona Pharma plc Soared
Tue, Dec 20, 2022 at 07:01 PM
Verona Pharma plc (VRNA:NASDAQ) soared at $18.59, a gain of 37.8%. On Tue, Dec 20, 2022, VRNA:NASDAQ touched a New 2-Week High of $18.59. The stock got featured on our News Catalysts scanner on Tue, Dec 20, 2022 at 03:30 PM in the 'MISCELLANEOUS' category. From Tue, Dec 06, 2022, the stock recorded 70.00% Up Days and 54.55% Green Days
About Verona Pharma plc (VRNA:NASDAQ)
Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.
Top 10 Gainers:
- IceCure Medical Ltd. (ICCM:NASDAQ), 177.6%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Erayak Power Solution Group Inc. (RAYA:NASDAQ), 47.54%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 39.93%
- Verona Pharma plc (VRNA:NASDAQ), 37.81%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 33.33%
- NextPlat Corp Com (New) (NXPL:NASDAQ), 30.6%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 27.64%
- IAMGOLD Corporation (IAG:NYSE), 25.27%
- Acasti Pharma Inc. (ACST:NASDAQ), 25.23%